United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read General business news RenaissanceRe finalizes $3bn acquisition of AIG’s Validus Re RenaissanceRe Holdings Ltd. (NYSE: RNR) today achieved a major milestone in its growth strategy by concluding the acquisition… byPallavi MadhirajuNovember 1, 2023